Androgenemic Phenotype Predicts Metabolic Disease and Androgen Burden in Polycystic Ovary Syndrome

Benzer Materyaller

• Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
  Yazar:: O'Reilly, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
  Yazar:: Punith Kempegowda, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-06-01)
• AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome
  Yazar:: O'Reilly, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Urinary Glucocorticoid Metabolite Excretion is Associated with Insulin Resistance Independent of BMI in Patients with Polycystic Ovary Syndrome
  Yazar:: O'Reilly, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Relationship between Androgen and Glucose Metabolism in Patients with Polycystic Ovary Syndrome
  Yazar:: WENG Ruiwen, LIU Yi, ZHANG Wei, LIU Hengwei
  Baskı/Yayın Bilgisi: (2022-11-01)